AlphaFold predicted structure
QDPR · P09417

Mean pLDDT
96.1/ 100
Very high
244 residues
Confidence breakdown
- Very high(≥ 90)95%
- Confident(70–90)1%
- Low(50–70)4%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
quinoid dihydropteridine reductase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Childhood onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalNeurotransmitter disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalAdult onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
dihydropteridine reductase deficiency
Hyperphenylalaninemia
Dystonia
6-pyruvoyl-tetrahydropterin synthase deficiency
BH4-deficient hyperphenylalaninemia A
hemoglobin E disease
hyperphenylalaninemia due to tetrahydrobiopterin deficiency
hereditary disease
hearing loss disorder
arthropathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Dihydropteridine reductase
Catalyzes the conversion of quinonoid dihydrobiopterin into tetrahydrobiopterin
Curated MONDO disease pages that list QDPR among their top associated genes.
QDPR · P09417

Mean pLDDT
96.1/ 100
Very high
244 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0